Tilray Brands Inc. (NASDAQ: TLRY) has captured investors’ attention following a significant increase in its stock price. On Thursday, shares experienced a remarkable surge of approximately 31.55% in after-hours trading, reaching $11.09. This rise is attributed to the recent announcement of the company’s new product line, Amped Live Resin Liquid Diamond.
Launch of Amped Live Resin Liquid Diamond
On Thursday, Tilray introduced the Amped Live Resin Liquid Diamond 1g 510 cartridges, marking a notable addition to its offerings. This launch represents Redecan’s first venture into live resin-liquid diamond product lines. The lineup includes popular strains such as Space Age CK and Blueberry DNTS.
- Product Composition: Each cartridge consists of 80% Legit Live Resin and 20% Liquid Diamonds. This formulation aims to enhance the consumer experience by delivering strain-specific terpenes and full-spectrum cannabinoids.
- Flavor Profiles:
- Space Age CK: Offers floral, fruit, and cake notes.
- Blueberry DNTS: Features a sweet and sour berry flavor.
Market Context and Regulatory Implications
The timing of this product launch coincided with a significant report from The Washington Post. It suggests that President Donald Trump may guide federal agencies to reconsider marijuana’s classification, transitioning from Schedule I to Schedule III. Schedule I substances, such as heroin, are viewed as having no accepted medical use, while Schedule III drugs have recognized therapeutic benefits.
Market Performance Insights
According to Tilray, live resin vapes have shown a 6.3% growth over the past six months in the Canadian cannabis market. Furthermore, Liquid Diamond products are noted as some of the best-selling vape formats across the country. Historically, vape product sales peak between December and February, aligning well with Amped’s launch schedule.
Distribution and Future Plans
The Amped Live Resin Liquid Diamond cartridges are currently available in Ontario and Alberta, with plans for nationwide distribution across Canada by early 2026. These products are intended exclusively for consumers aged 19 and older.
Stock Performance Overview
Despite a year-to-date decline of 42.26%, Tilray’s stock has rebounded impressively, with a 102.64% increase over the last six months. With a market capitalization of approximately $9.49 billion, TLRY shares have fluctuated between $3.51 and $23.20 over the past year. As of Thursday’s close, the stock was priced at $8.43, reflecting a 2.06% increase.
The recent dynamics surrounding Tilray’s stock and product launch highlight the potential for growth within the cannabis sector. Investors and consumers alike are keenly observing these developments as they unfold.
